Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fundraising
Health Tech
Oura hits $11B valuation on $900M series E round
Oura landed a $900 million series E, reflecting the company’s booming revenue and sales over the last year. Its valuation hit $11 billion.
Emma Beavins
Oct 14, 2025 7:01am
Fierce Biotech
Pivotal, Wellcome Leap invest $100M in women's health research
Sep 10, 2025 10:35am
Nabla banks $70M series C, expands into agentic AI
Jun 17, 2025 4:30pm
Payer Roundup—PBMs under spotlight; New ACO coalition forms
Apr 30, 2025 3:15pm
PitchBook: Digital health, health IT funding slumps in Q2
Sep 13, 2023 6:15pm
PE deals dip in Q2 due to debt costs, Pitchbook finds
Aug 15, 2023 11:31am